Novel Location-Grading-Node-Metastasis Staging System in Patients With Head and Neck Soft Tissue Sarcoma

Area of Science:

• Oncology
• Surgical Pathology

Background:

• Head and neck soft tissue sarcoma (HN-STS) staging currently mirrors that of trunk and extremity sarcomas.
• The existing American Joint Committee on Cancer (AJCC) staging system has demonstrated limitations in accurately predicting prognosis for HN-STS.

Purpose of the Study:

• To introduce and validate a novel location-grading-node-metastasis (LGNM) staging system for HN-STS.
• To enhance the accuracy of prognostic stratification by incorporating primary tumor location.

Main Methods:

• A retrospective case series analysis of 471 HN-STS patients diagnosed between 1990 and 2021.
• Development and validation of the LGNM staging system, categorizing tumors into four risk levels (L1-L4) based on location and local invasion.
• Comparative analysis of the LGNM system against the 7th and 8th editions of the AJCC staging systems using overall survival (OS) rates and statistical measures.

Main Results:

• The AJCC T classification inadequately predicts HN-STS prognosis.
• The LGNM system effectively stratified patients into four stages (I-IV) with significant survival differences (5-year OS: Stage I 96.9%, Stage II 78.4%, Stage III 37.1%, Stage IV 7.1%).
• The LGNM staging system exhibited superior predictive accuracy and concordance compared to the AJCC staging system.

Conclusions:

• The LGNM staging system demonstrates improved homogeneity and discriminatory power for HN-STS risk stratification.
• This novel system offers enhanced prognosis prediction capabilities compared to current AJCC staging guidelines.
• The LGNM system provides a more accurate method for evaluating patient outcomes in HN-STS.